|Five Named to NIAID Advisory Council
The National Institute of Allergy and Infectious Diseases (NIAID)
today announced the appointment of five new members to the National
Advisory Allergy and Infectious Diseases Council, its principal
advisory body. NIAID is part of National Institutes of Health (NIH),
an agency within the Department of Health and Human Services.
The council provides recommendations on the conduct and support
of research, including training young scientists and disseminating
health information derived from NIAID research. It embodies a diverse
perspective on science, health and the human impact of disease.
The council is composed of physicians, scientists and representatives
of the public who contribute their time and expertise for a four-year
The new council members are Robert Brooks, M.D., of the Florida
State University College of Medicine; Satya Dandekar, Ph.D., from
the University of California, Davis; Sharon C. Kiely, M.D., M.P.H.,
of Allegheny General Hospital in Pittsburgh and Drexel University
School of Medicine; Marc E. Rothenberg, M.D., Ph.D., from the Cincinnati
Children’s Hospital Medical Center; and David S. Wilkes, M.D.,
of the Indiana University School of Medicine.
Robert Brooks, M.D., is associate dean for health affairs and
professor of family medicine and rural health at the Florida State
University College of Medicine in Tallahassee. He serves on the
Florida Governor's Health Information Technology Advisory Board
and the Florida Medicaid Reform Advisory Council. Previously, he
was chief of infectious diseases at the Orlando Regional Medical
Center. He served in the Florida House of Representatives from
1994 until late 1998 when he was appointed Secretary of the Florida
Department of Health.
Satya Dandekar, Ph.D., is professor and chair, Department of Internal
Medicine, University of California, Davis. Her expertise and research
interests are in the areas of HIV/AIDS. She has participated in
the review of grant applications and program projects for several
NIH committees and has been a scientific reviewer for numerous
journals and boards. She also has been invited to lecture on clinical
infectious diseases for professional organizations.
Sharon C. Kiely, M.D., M.P.H., is medical director for quality
and patient safety at Allegheny General Hospital in Pittsburgh
and associate professor of medicine at Drexel University School
of Medicine in Philadelphia. She has served on the United Network
for Organ Sharing board of directors as well as the HHS Secretary’s
Advisory Committee on Xenotransplantation. She is a specialist
in internal medicine and has focused her clinical, research and
volunteer efforts on juvenile diabetes, medical education and care
to underserved populations, including those with HIV/AIDS.
Marc E. Rothenberg, M.D., Ph.D., is professor of pediatrics and
director of the Division of Allergy and Immunology at Cincinnati
Children’s Hospital Medical Center. He also serves as director
for the Cincinnati Center for Eosinophilic Disorders. His research
focuses on molecular mechanisms of allergic inflammation. He studies
the genes and molecules involved in allergic responses, cellular
and molecular immunology, and the development and analysis of genetically
engineered and antigen-driven models of allergic disease in mice.
He also conducts translational clinical trials.
David S. Wilkes, M.D., is Dr. Calvin H. English Professor of Medicine,
Microbiology and Immunology at the Indiana University School of
Medicine in Indianapolis. A pulmonary and critical care physician,
he is also the director for the Center for Immunobiology at Indiana.
He researches the immunopathogenesis of lung transplant rejection
with a focus on alloimmune-induced autoimmunity in lung transplant
recipients. Dr. Wilkes has served as a NIH study section member
and co-chaired the NIH-sponsored workshop on Lung Transplantation:
Opportunities for Research and Clinical Advancement.
NIAID is a component of the National Institutes of Health. NIAID
supports basic and applied research to prevent, diagnose and treat
infectious diseases such as HIV/AIDS and other sexually transmitted
infections, influenza, tuberculosis, malaria and illness from potential
agents of bioterrorism. NIAID also supports research on basic immunology,
transplantation and immune-related disorders, including autoimmune
diseases, asthma and allergies. News releases, fact sheets and
other NIAID-related materials are available on the NIAID Web site
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and
Centers and is a component of the U.S. Department of Health and
Human Services. It is the primary federal agency for conducting
and supporting basic, clinical and translational medical research,
and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and
its programs, visit www.nih.gov.